Markets

Stock Market LIVE: GIFT Nifty flat; Asian markets down; Investors eye RBI MPC's policy decision

Sensex Today | Stock Market LIVE Updates on December 5, 2025: D-Street investors await the decision of the Monetary Policy Committee (MPC) of the Reserve Bank of India (RBI) on the key interest rates

JM Financial starts coverage on KPR Mill with 'Buy'; check target price

JM Financial has set a target price of ₹1,215 per share, implying an upside potential of 21 per cent

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Mphasis up 2% on innovation program update; PL Capital upgrades to 'Buy'

Domestic brokerage PL Capital has upgraded its rating on Mphasis shares to 'Buy' from 'Accumulate', with a revised target price of ₹3,310 per share

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Here's why Adani Enterprises share price rose 2% in trade on December 4

Adani Enterprises informed the exchanges that AdaniConneX Private Limited, a joint venture of the company, has incorporated a wholly owned subsidiary (WOS) namely 'AdaniConneX Hyderabad Three Limited'

DIC India shares gain 5% after Karnataka GST authorities slash penalty

The upward movement in DIC India's share price came after the Karnataka GST department revised the total GST demand against the company to ₹3.81 lakh from ₹6.71 crore

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Motilal Oswal retains 'Buy' on Aurobindo Pharma as FY26-28 prospects shine

Tushar Manudhane, Vipul Mehta, and Eshita Jain, research analysts at MOFSL, value Aurobindo Pharma at 16 times 12-month forward earnings, assigning a target price of ₹1,430

Emmvee Photovoltaic gains 4%, hits all-time high on strong Q2 performance

Emmvee Photovoltaic stock was trading at ₹243.5, up 1.85 per cent compared to the previous session's close of ₹239.35 on the NSE

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times

Here's why Angel One share price declined 6% in trade on December 3

Angel One stock is still over 32 per cent higher than its 52-week low of ₹1,941 touched on the NSE earlier this year on March 13

Corona Remedies IPO price band at ₹1,008-1,062; check dates, GMP, objective

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

Motilal Oswal sector of the week: Capital goods; check top stock bets here

Motilal Oswal said that stable execution and rising export momentum could shape capital goods sectors' H2FY26 outlook

Meesho vs Aequs vs Vidya Wires IPO: Which one should you bet on?

Analysts remain largely positive on Meesho IPO and Vidya Wires IPO, citing strong growth prospects and operational efficiency, while views on Aequs IPO are cautious

SC rejects Reliance plea over ₹30 lakh fine for not disclosing Jio-FB deal

In June 2022, Sebi imposed a penalty of ₹30 lakh on Reliance Industries for not making a prompt clarification to stock exchanges regarding the Jio-Facebook deal

Wakefit sets IPO price band at ₹185-195; check key dates, GMP, objective

Wakefit Innonvation aims to raise ₹1,288 crore through a fresh issue of 19.3 million shares, amounting to ₹377.18 crore, and an OFS of 46.8 million shares, amounting to ₹911.7 crore

Motilal Oswal says Adani Ports is set for multi-year expansion; here's why

The brokerage has retained its Buy rating on Adani Ports shares, with a revised target price of ₹1,770, implying a 16 per cent upside from the current market price of ₹1,531 per share

Near-term margins for cement companies to remain under pressure

Weak Q3 pricing persists despite Y-o-Y profit gains, as aggressive capacity expansion overshadows near-term demand

Ravelcare IPO booked 7x on Day 1; strong retail demand, GMP at 40%

Ravelcare IPO received bids for 9.22 million equity shares compared to the issue size of 1.32 million shares